For example, insulin sensitivity in diabetes treatment could be associated with the expression pattern of specific miRNAs and therefore, hypothetically, synthetic miRNA agents can be used to manipulate drug resistance in diabetes treatment [84]. Here, INS is linked to diabetes mellitus.